PreveCeutical Medical Inc (CNSX:PREV – Get Free Report) insider Michael Moeller acquired 650,000 shares of the firm’s stock in a transaction that occurred on Friday, March 14th. The shares were bought at an average cost of $0.03 per share, for a total transaction of $16,250.00.
PreveCeutical Medical Price Performance
About PreveCeutical Medical
PreveCeutical Medical Inc, a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity.
Featured Stories
- Five stocks we like better than PreveCeutical Medical
- Investing in the High PE Growth Stocks
- How to Build the Ultimate Everything ETF Portfolio
- What is the Nikkei 225 index?
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for PreveCeutical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PreveCeutical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
